Gerresheimer (GXI) Given a €60.00 Price Target at Hauck & Aufhaeuser

Gerresheimer (ETR:GXI) received a €60.00 ($69.77) price target from analysts at Hauck & Aufhaeuser in a research report issued on Monday. The brokerage currently has a “sell” rating on the stock. Hauck & Aufhaeuser’s target price would indicate a potential downside of 12.02% from the company’s current price.

GXI has been the topic of several other research reports. Goldman Sachs Group set a €70.00 ($81.40) target price on Gerresheimer and gave the company a “neutral” rating in a research note on Monday, June 18th. Deutsche Bank set a €77.00 ($89.53) target price on Gerresheimer and gave the company a “buy” rating in a research note on Tuesday, June 19th. Commerzbank set a €68.00 ($79.07) target price on Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, June 21st. JPMorgan Chase & Co. set a €79.40 ($92.33) target price on Gerresheimer and gave the company a “neutral” rating in a research note on Friday, July 6th. Finally, Credit Suisse Group set a €72.00 ($83.72) target price on Gerresheimer and gave the company a “buy” rating in a research note on Monday, July 9th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €72.33 ($84.11).

Shares of GXI opened at €68.20 ($79.30) on Monday. Gerresheimer has a 1-year low of €59.97 ($69.73) and a 1-year high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: What does RSI mean?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply